Real-time enrollment status for this acute myeloid leukaemia clinical trial
Current Status
Recruiting
Checked: October 2, 2026 at 2:34 AM UTC
| NCT Number | NCT07723703 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukaemia |
| Phase | PHASE1 |
| Target Enrollment | 54 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Amphista Therapeutics Ltd |
| Last Updated on CT.gov | September 15, 2026 (2 weeks ago) |
As of October 2, 2026: Clinical trial NCT07723703 is currently recruiting participants. This phase1 study for acute myeloid leukaemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Amphista Therapeutics Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07723703 is actively recruiting participants as of October 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07723703 was last updated 2 weeks ago (September 15, 2026). HelloStudys verifies this status automatically.